APPLICATION
ANDA205232
TYPE
ANDA
ORIGINAL APPROVAL
2020-04-06
LATEST ACTION
2026-05-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
PERPHENAZINEPrescription
PERPHENAZINE 16MG · TABLET · ORAL
PERPHENAZINEPrescription
PERPHENAZINE 4MG · TABLET · ORAL
PERPHENAZINEPrescription
PERPHENAZINE 8MG · TABLET · ORAL
PERPHENAZINEPrescription
PERPHENAZINE 2MG · TABLET · ORAL
Approval history
2026-05-01Manufacturing (CMC) · Supplement 3 · unknownAP
2025-01-22Labeling · Supplement 2 · standardAP
2020-04-06UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.